These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8833918)

  • 1. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
    Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K
    J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.
    Akdis CA; Blesken T; Wymann D; Akdis M; Blaser K
    Eur J Immunol; 1998 Mar; 28(3):914-25. PubMed ID: 9541587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production.
    Blaser K
    Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro.
    Akdis CA; Blesken T; Akdis M; Alkan SS; Heusser CH; Blaser K
    Eur J Immunol; 1997 Sep; 27(9):2351-7. PubMed ID: 9341780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and mechanisms of human immune responses to bee venom phospholipase A2.
    Blaser K; Carballido J; Faith A; Crameri R; Akdis C
    Int Arch Allergy Immunol; 1998 Sep; 117(1):1-10. PubMed ID: 9751842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic activity of soluble phospholipase A2 does not affect the specific IgE, IgG4 and cytokine responses in bee sting allergy.
    Wymann D; Akdis CA; Blesken T; Akdis M; Crameri R; Blaser K
    Clin Exp Allergy; 1998 Jul; 28(7):839-49. PubMed ID: 9720818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin 10 in specific immunotherapy.
    Akdis CA; Blesken T; Akdis M; Wüthrich B; Blaser K
    J Clin Invest; 1998 Jul; 102(1):98-106. PubMed ID: 9649562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers.
    Boonpiyathad T; Meyer N; Moniuszko M; Sokolowska M; Eljaszewicz A; Wirz OF; Tomasiak-Lozowska MM; Bodzenta-Lukaszyk A; Ruxrungtham K; van de Veen W
    Allergy; 2017 Mar; 72(3):407-415. PubMed ID: 27341567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.
    Carballido JM; Carballido-Perrig N; Terres G; Heusser CH; Blaser K
    Eur J Immunol; 1992 Jun; 22(6):1357-63. PubMed ID: 1601030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.
    Jutel M; Pichler WJ; Skrbic D; Urwyler A; Dahinden C; Müller UR
    J Immunol; 1995 Apr; 154(8):4187-94. PubMed ID: 7706753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.
    Carballido JM; Carballido-Perrig N; Oberli-Schrämmli A; Heusser CH; Blaser K
    J Allergy Clin Immunol; 1994 Apr; 93(4):758-67. PubMed ID: 8163785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells.
    Akdis CA; Blesken T; Akdis M; Alkan SS; Wüthrich B; Heusser CH; Blaser K
    J Allergy Clin Immunol; 1997 Mar; 99(3):345-53. PubMed ID: 9058690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy.
    Akdis CA; Blaser K
    FASEB J; 1999 Apr; 13(6):603-9. PubMed ID: 10094921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
    Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
    Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2.
    Carballido JM; Carballido-Perrig N; Kägi MK; Meloen RH; Wüthrich B; Heusser CH; Blaser K
    J Immunol; 1993 Apr; 150(8 Pt 1):3582-91. PubMed ID: 7682244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy.
    McHugh SM; Deighton J; Stewart AG; Lachmann PJ; Ewan PW
    Clin Exp Allergy; 1995 Sep; 25(9):828-38. PubMed ID: 8564721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial.
    Fellrath JM; Kettner A; Dufour N; Frigerio C; Schneeberger D; Leimgruber A; Corradin G; Spertini F
    J Allergy Clin Immunol; 2003 Apr; 111(4):854-61. PubMed ID: 12704369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling.
    Faith A; Akdis CA; Akdis M; Joss A; Wymann D; Blaser K
    J Immunol; 1999 Feb; 162(3):1836-42. PubMed ID: 9973449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.
    Kussebi F; Karamloo F; Rhyner C; Schmid-Grendelmeier P; Salagianni M; Mannhart C; Akdis M; Soldatova L; Markovic-Housley Z; Von Beust BR; Kündig T; Kemeny DM; Blaser K; Crameri R; Akdis CA
    J Allergy Clin Immunol; 2005 Feb; 115(2):323-9. PubMed ID: 15696088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.